Pro Medicus Limited ( (AU:PME) ) has issued an announcement.
Pro Medicus Limited announced a multi-year research collaboration agreement with UCSF to leverage the Visage AI Accelerator platform for AI research and development aimed at product commercialization. This collaboration aligns with Pro Medicus’s strategy to integrate AI into healthcare imaging, potentially leading to innovative solutions that improve patient outcomes and strengthen the company’s position in the imaging IT industry.
More about Pro Medicus Limited
Pro Medicus Limited is a leading healthcare informatics company founded in 1983, providing a comprehensive range of medical imaging software and services to hospitals, imaging centers, and healthcare groups globally. The company acquired Visage Imaging in 2009, enhancing its position as a global provider of advanced medical imaging solutions. Its Visage 7 suite offers a fast, scalable platform deployable in both public and private cloud environments, with a comprehensive suite of RIS, PACS, AI, and e-health solutions.
YTD Price Performance: -19.66%
Average Trading Volume: 1,634
Technical Sentiment Signal: Hold
Current Market Cap: $13.32B
See more insights into PME stock on TipRanks’ Stock Analysis page.